Yesterday, Tuesday 23 April 2024, the shares of the ophthalmic‑drug development company Oculis Holding AG were listed on the Nasdaq Iceland Main Market.
Arctica Finance managed the listing process and advised the company on an ISK 8 billion (USD 59 million) equity raise through a private placement conducted ahead of the listing. Legal advice was provided by the law firms BBA//Fjeldco, Cooley LLP, and Vischer AG.
Oculis is now the second company to be dual‑listed in both Iceland and the United States, having been listed on the U.S. stock market since 3 March 2023.
Arctica Finance congratulates the company on this milestone.
